2023
Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019
Sheth S, Johnson N, Sullivan E, Torres A, Oliveira C, Niccolai L. Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019. Journal Of Women's Health 2023, 33: 28-32. PMID: 37943625, PMCID: PMC10794823, DOI: 10.1089/jwh.2022.0456.Peer-Reviewed Original ResearchConceptsMid-adult womenVaccination statusHPV vaccinationHPV vaccineHuman Papillomavirus Vaccination StatusHPV vaccination statusHuman papillomavirus vaccinationAge 26 yearsHealth care providersCross-sectional surveyPapillomavirus vaccinationUnvaccinated womenVaccinated womenVaccine informationCare providersVaccinationAdult womenVaccineWomenBehavioral correlatesCorrelatesStatusPotential benefitsYearsParticipantsHuman papillomavirus vaccine effectiveness by age at vaccination: A systematic review
Ellingson M, Sheikha H, Nyhan K, Oliveira C, Niccolai L. Human papillomavirus vaccine effectiveness by age at vaccination: A systematic review. Human Vaccines & Immunotherapeutics 2023, 19: 2239085. PMID: 37529935, PMCID: PMC10399474, DOI: 10.1080/21645515.2023.2239085.Peer-Reviewed Original ResearchConceptsVaccine effectivenessSystematic reviewHuman Papillomavirus Vaccine EffectivenessVaccine-type HPV infectionYounger ageHigh vaccine effectivenessHuman papillomavirus vaccineVaccine effectiveness studiesYounger age groupsAdolescents ages 15Adolescents ages 9HPV infectionHPV vaccineVaccine initiationPapillomavirus vaccineTime vaccinationAnogenital wartsCervical abnormalitiesCervical cancerDisease outcomeAge groupsOlder ageEffectiveness studiesAge 15AgeFailure to Complete Multidose Vaccine Series in Early Childhood.
Michels S, Niccolai L, Hadler J, Freeman R, Albers A, Glanz J, Daley M, Newcomer S. Failure to Complete Multidose Vaccine Series in Early Childhood. Pediatrics 2023, 152 PMID: 37489285, PMCID: PMC10389773, DOI: 10.1542/peds.2022-059844.Peer-Reviewed Original ResearchMeSH KeywordsChild, PreschoolFamily CharacteristicsHumansInfantVaccinationVaccination CoverageVaccinesConceptsVaccine seriesVaccination patternsUS childrenAdditional vaccine doseEarly childhood immunizationVaccine dosePreventable diseaseChildhood immunizationSeries completionNumber of childrenSociodemographic factorsInsurance coverageStrong associationOptimal protectionEarly childhoodBinomial regressionChildrenDosesAssociationStructural barriersCoverage goalsVaccinationImmunizationA review of data systems for assessing the impact of HPV vaccination in selected high-income countries
Wang W, Kothari S, Khoury H, Niccolai L, Garland S, Sundström K, de Pouvourville G, Bonanni P, Chen Y, Franco E. A review of data systems for assessing the impact of HPV vaccination in selected high-income countries. Expert Review Of Vaccines 2023, 22: 161-179. PMID: 36576068, DOI: 10.1080/14760584.2023.2162505.Peer-Reviewed Original ResearchConceptsHigh-income countriesHPV vaccinationCervical cancer prevention policyCharacteristics of HPVHuman papillomavirus vaccinationCervical screening programmeEarly detection measuresCancer prevention policiesWorld Health OrganizationPapillomavirus vaccinationCervical cancerVaccination coverageDisease outcomeScreening programElimination effortsGlobal eliminationPrevention programsTreatment programData SystemVaccinationHealth OrganizationHPVTargeted reviewPrevention policiesUnited States
2022
Messaging of Different Disease Outcomes for Human Papillomavirus Vaccination: A Systematic Review
Niccolai L, Johnson N, Torres A, Sullivan E, Hansen C. Messaging of Different Disease Outcomes for Human Papillomavirus Vaccination: A Systematic Review. Journal Of Adolescent Health 2022, 72: 334-343. PMID: 36529616, DOI: 10.1016/j.jadohealth.2022.10.018.Peer-Reviewed Original Research